[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile

This compound is a synthetic small molecule belonging to the class of quinazolinamines, characterized by a quinazoline core structure with an appended pyrazole and phenyl acetonitrile moiety. It is listed as an experimental drug and has been studied primarily for its activity as a kinase inhibitor. The main known molecular target is the proto-oncogene tyrosine-protein kinase Src, suggesting potential utility in oncology or related research areas where Src inhibition may be beneficial. There are no approved indications or marketed formulations for this compound, and it remains at the experimental stage of development[2].

Other names

2-[4-{4-(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin–2–yl}amino)phenyl]acetonitrileQ27459892Q-27459892Q 27459892